Regulation of fibronectin by thyroid hormone receptors

Journal of Molecular Endocrinology

Volumn 33, Issue 2, 2004, Pages 445-458

  Lin, Kwang Huei ^a   Chen, Chia Yu ^a   Chen, Shen Liang ^a   Yen, Chun Che ^a   Huang, Ya Hui ^a   Shih, Chung Hsuan ^a   Shen, Jiann Jong ^a   Yang, Rong Chi ^b   Wang, Chia Siu ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOHEXIMIDE; FIBRONECTIN; LIOTHYRONINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; SMAD3 PROTEIN; SMAD4 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; THYROID HORMONE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HORMONE ACTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

CARCINOMA, HEPATOCELLULAR; CYCLOHEXIMIDE; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; LIVER NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASES; SMAD3 PROTEIN; SMAD4 PROTEIN; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRIIODOTHYRONINE; TUMOR CELLS, CULTURED;

EID: 7244221740     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01505     Document Type: Article

References (42)

1. Balza E, Borsi L, Allemanni G & Zardi L 1988 Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Letters 228 42-44.
2. Baumgartner-Parzer SM, Wagner L, Reining G, Sexl V, Nowotny P, Muller M, Brunner M & Waldhausl W 1997 Increase by tri-iodothyronine of endothelin-1, fibronectin and von Willebrand factor in cultured endothelial cells. Journal of Endocrinology 154 231-239.
3. Bhat MK, McPhie P & Cheng SY 1995 Interaction of thyroid hormone nuclear receptor with antibody: characterization of the thyroid hormone binding site. Biochemical and Biophysical Research Communications 210 464-471.
4. Borsi L, Castellani P, Risso AM, Leprini A & Zardi L 1990 Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Letters 261 175-178.
5. Calloni GW, Alvarez-Silva M, Vituri C & Trentin AG 2001 Thyroid hormone deficiency alters extracellular matrix protein expression in rat brain. Developmental Brain Research 126 121-124.
6. Caputi M, Melo CA & Baralle FE 1995 Regulation of fibronectin expression in rat regenerating liver. Nucleic Acids Research 23 238-243.
7. Chang C, Lin Y, O-Lee TW, Chou CK, Lee TS, Liu TJ, P'Eng FK, Chen TY & Hu CP 1983 Induction of plasma protein secretion in a newly established human hepatoma cell line. Molecular and Cellular Biology 3 1133-1137.
8. Cheng SY 2000 Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Reviews in Endocrine and Metabolic Disorders 1 9-18.
9. Corica F, Allegra A, Corsonello A, Buemi M, Rubino F, Bonanzinga S, Ruello A & Ceruso D 1998 Increased transforming growth factor-beta1 plasma concentration is associated with high plasma 3,3′,5′-tri-iodothyronine in elderly patients with nonthyroidal illnesses. European Journal of Endocrinology 138 47-50.
10. Ehretsmann CP, Chandler LA & Bourgeois S 1995 A nuclear post-transcriptional mechanism mediates the induction of fibronectin by glucocorticoids. Molecular and Cellular Endocrinology 110 185-194.
11. Flores-Morales A, Gullberg H, Fernandez L, Stahlberg N, Lee NH, Vennstrom B & Norstedt G 2002 Patterns of liver gene expression governed by TRbeta. Molecular Endocrinology 16 1257-1268.
12. Hagiwara T, Suzuki H, Kono I, Kashiwagi H, Akiyama Y & Onozaki K 1990 Regulation of fibronectin synthesis by interleukin-1 and interleukin-6 in rat hepatocytes. American Journal of Pathology 136 39-47.
13. Hocevar BA, Brown TL & Howe PH 1999 TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO Journal 18 1345-1356.
14. Hynes R 1985a Molecular biology of fibronectin. Annual Review of Cell and Developmental Biology 1 67-90.
15. Hynes RO 1985b Fibronectins: a family of complex and versatile adhesive glycoproteins derived from a single gene. The Harvey Lectures 81 133-152.
16. Islami D, Shoukir Y, Dupont P, Campana A & Bischof P 2001 Is cellular fibronectin a biological marker for pre-eclampsia? European Journal of Obstetrics, Gynecology, and Reproductive Biology 97 40-45.
17. Itoh S, Itoh F, Goumans MJ & Ten Dijke P 2000 Signaling of transforming growth factor-beta family members through Smad proteins. European Journal of Biochemistry 267 6954-6967.
18. Kim HY & Wolf G 1987 Vitamin A deficiency alters genomic expression for fibronectin in liver and hepatocytes. Journal of Biological Chemistry 262 365-337.
19. Kuang WW, Thompson DA, Hoch RV & Weigel RJ 1998 Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Research 26 1116-1123.
20. Kyriakis JM & Avruch J 1996 Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18 567-577.
21. Lazar J, Desvergne B, Zimmerman EC, Zimmer DB, Magnuson MA & Nikodem VM 1994 A role for intronic sequences on expression of thyroid hormone receptor alpha gene. Journal of Biological Chemistry 269 20352-20359.
22. Lee J, Murata Y, Seo H, Menjo M, Torii S & Matsui N 1992 The effect of thyroid hormone on fibronectin messenger ribonucleic acid levels in primary cultured rat hepatocytes. Endocrinology 130 2733-2738.
23. Liao JK, Zulueta JJ, Yu FS, Peng HB, Cote CG & Hassoun PM 1995 Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. Journal of Clinical Investigation 96 2661-2666.
24. Lin K, Chen S, Zhu XG, Shieh H, McPhie P & Cheng S 1997 The gene regulating activity of thyroid hormone nuclear receptors is modulated by cell-type specific factors. Biochemical and Biophysical Research Communications 238 280-284.
25. Lin KH, Shieh HY & Hsu HC 2000 Negative regulation of the antimetastatic gene Nm23-H1 by thyroid hormone receptors. Endocrinology 141 2540-2547.
26. Lin KH, Wang WJ, Wu YH & Cheng SY 2002 Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor. Endocrinology 143 467-475.
27. Marais R & Marshall CJ 1996 Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Survey 27 101-125.
28. Miller LD, Park KS, Guo QM, Alkharouf NW, Malek RL, Lee NH, Liu ET & Cheng SY 2001 Silencing of Wnt signaling and activation of multiple metabolic pathways in response to thyroid hormone-stimulated cell proliferation. Molecular and Cellular Biology 21 6626-6639.
29. Murata Y, Seo H, Sekiguchi K, Imai T, Lee J & Matsui N 1990 Specific induction of fibronectin gene in rat liver by thyroid hormone. Molecular Endocrinology 4 693-699.
30. Pande H, Terramani T, Tressel T, Churchill MA, Hawkins GG & Zaia JA 1990 Altered expression of fibronectin gene in cells infected with human cytomegalovirus. Journal of Virology 64 1366-1369.
31. Pankov R & Yamada KM 2002 Fibronectin at a glance. Journal of Cell Science 115 3861-3863.
32. Samuels HH, Stanley F & Casanova J 1979 Depletion of L-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105 80-85.
33. Sekiguchi K, Klos AM, Kurachi K, Yoshitake S & Hakomori S 1986 Human liver fibronectin complementary DNAs: identification of two different messenger RNAs possibly encoding the alpha and beta subunits of plasma fibronectin. Biochemistry 25 4936-4941.
34. Shanker G & Sawhney R 1996 Retinoic acid: identification of specific receptors through which it may mediate transcriptional regulation of fibronectin gene in bovine lens epithelial cells. Cell Biology International 20 613-619.
35. Shirakami A, Hirai Y, Takeichi T, Nishino H, Inomoto T, Watanabe S, Shigekiyo T, Kawauchi S, Saito H & Saito S 1986 Changes in plasma fibronectin levels in thyroid diseases. Hormone and Metabolism Research 18 345-348.
36. Srebrow A, Blaustein M & Kornblihtt AR 2002 Regulation of fibronectin alternative splicing by a basement membrane-like extracellular matrix. FEBS Letters 514 285-289.
37. Suzuki M, Oda E, Nakajima T, Sekiya S & Oda K 1998 Induction of Sp1 in differentiating human embryonal carcinoma cells triggers transcription of the fibronectin gene. Molecular and Cellular Biology 18 3010-3020.
38. Tamaroglio TA & Lo CS 1994 Regulation of fibronectin by insulin-like growth factor-I in cultured rat thoracic aortic smooth muscle cells and glomerular mesangial cells. Experimental Cell Research 215 338-346.
39. Vollmer G, Hopert AC, Ellerbrake N, Wunsche W & Knuppen R 1995 Fibronectin is an estrogen-repressed protein in RUCA-I rat endometrial adenocarcinoma cells. Journal of Steroid Biochemistry and Molecular Biology 54 131-139.
40. Watzke H, Schwarz HP & Weissel M 1987 Fibronectin during thyroid hormone replacement therapy. Thrombosis Research 46 347-353.
41. Wood WM, Dowding JM, Bright TM, McDermott MT, Haugen BR, Gordon DF & Ridgway EC 1996 Thyroid hormone receptor beta2 promoter activity in pituitary cells is regulated by Pit-1. Journal of Biological Chemistry 271 24213-24220.
42. Woodgett JR, Kyriakis JM, Avruch J, Zon LI, Zanke B & Templeton DJ 1996 Reconstitution of novel signalling cascades responding to cellular stresses. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 351 135-141; discussion 142.